Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2826 of 5804
-
Smart dosing for IBD: Computer-Guided drug delivery shows promise
Disease control OngoingThe OPTIMIZE Trial compares whether iDose dashboard-driven infliximab dosing (iDose-driven dosing) is more effective and safer than standard infliximab dosing for inducing and maintaining disease remission in inflammatory bowel disease.
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New toolkit aims to boost HIV prevention in african american women
Prevention CompletedPre-exposure prophylaxis may be a viable option for African American women at-risk for HIV infection, but few studies have identified optimal strategies to reach African American women in need of Pre-Exposure Prophylaxis nor examined effective strategies to scale-up Pre-Exposure …
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Herbal ointment shows promise for chronic pain relief
Symptom relief CompletedA prospective cohort study on the treatment of chronic pain in the musculoskeletal system with Compound Nanxing Pain Relief Ointment. This study adopted an observational research design. Through a cohort study, patient medical records were collected to meet the criteria of chroni…
Sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Pelvic floor therapy tested as new fix for ED and premature ejaculation
Symptom relief Recruiting nowThe objective of this clinical trial is to evaluate the effectiveness of pelvic floor therapy for the management of erectile dysfunction and premature ejaculation in patients with erectile dysfunction and premature ejaculation. The main question to answer is: What is the effecti…
Phase: NA • Sponsor: Boston Medical Group • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New heart stent under Real-World watch: will it hold up?
Disease control OngoingProspective registry intended to evaluate clinical outcomes of ihtDEStiny drug eluting coronary stent.
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Electric pulses to the gut: a new hope for diabetes?
Disease control CompletedThis is a multi-center, open-label study to assess the feasibility and preliminary safety of the Endogenex Device for endoscopic duodenal mucosal regeneration in patients with type 2 Diabetes inadequately controlled on 2-3 non-insulin glucose-lowering medications.
Phase: NA • Sponsor: Endogenex, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a pill reach and fight aggressive brain tumors? early trial hints at possibility
Disease control OngoingThis is an open-label, multi-center Phase 0 study with an expansion phase that will enroll up to 24 participants with newly-diagnosed glioblastoma and up to 18 recurrent glioma participants with IDH mutation and ATRX loss. The trial will be composed of a Phase 0 component (subdiv…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New blood test aims to catch lung transplant problems early
Knowledge-focused OngoingALAMO is a prospective, multi-center, perspective, registry of patients receiving LungCare™ (AlloSure®-Lung, AlloMap Lung, and HistoMap) for surveillance post-transplant. This study aims to evaluate the diagnostic performance characteristics of AlloSure Lung (dd-cfDNA) to detect …
Sponsor: CareDx • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New foot rehab aims to stop ankle sprains from coming back
Disease control OngoingThe overall objective of this study is to examine the effects of a 6-week foot-intensive rehabilitation (FIRE) program on lateral ankle sprain (LAS) re-injury rates, CAI symptoms, sensorimotor function, and self-reported disability in CAI patients.
Phase: NA • Sponsor: Matthew Hoch • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for Hard-to-Treat myeloma? early trial tests Two-Drug attack
Disease control CompletedThis study will test the safety of TTI-622 in combination with daratumumab hyaluronidase-fihj in people with relapsed/refractory multiple myeloma. The researchers look for the highest dose TTI-622 that causes few or mild side effects in participants when given in combination with…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a common transplant drug tame dangerous brain aneurysms?
Disease control Recruiting nowThe objective of this study is to explore the effects of Sirolimus on the underlying molecular alterations of cerebral aneurysms.
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Blood tests could reveal who benefits from immunotherapy
Knowledge-focused OngoingImmunotherapy is widely administrated as anticancer treatment in metastatic setting. Despite a proved efficacy in several cancer types and clinical situations, it exists a wide variability of responses in terms of efficacy and toxicity. The rate of responders depends mostly on th…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:10 UTC
-
Can a simple bladder tuck help men regain control after prostate surgery?
Symptom relief TerminatedThis phase III trial compares the effects of robot-assisted radical prostatectomy (RARP) with or without vesicopexy on urinary continence (a person's ability to control their bladder) and quality of life in patients with cancer of the prostate. RARP is the most adopted surgical a…
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New drug combo HRS8807 and SHR6390 targets tough breast cancer
Disease control OngoingThe study is to assess safety and tolerability of HRS8807 monotherapy and in combination with SHR6390 in subjects with metastatic or locally advanced breast cancer in order to estimate the Dose-Limiting Toxicity (DLT), Maximum Tolerated Dose (MTD) and select the Recommended Phase…
Phase: PHASE1 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Veterans' surgery outcomes could improve with Team-Based care
Disease control OngoingThe PAUSE Trial is a pragmatic, randomized clinical trial for Veterans scheduled for elective surgery at 3 large VA facilities (Palo Alto, Houston, and Nashville). The PAUSE Trial focuses on cooperation between providers of various disciplines in order to provide better care. Vet…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Freezing spray could help patients breathe easier without repeat surgeries
Disease control OngoingBenign central airway stenosis (BCAS) is an important cause of both pulmonary morbidity and mortality. Notable causes include post-intubation stenosis, collagen vascular diseases, airway trauma, infectious and idiopathic subglottic stenosis (iSGS). Surgery is the preferred defini…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New heart valve study aims to improve lives of heart defect patients
Disease control OngoingThe purpose of this study is to characterize the functionality of transcatheter implantation of the Medtronic Harmony Transcatheter Pulmonary Valve (TPV) achieved by real-world implanters.
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New therapy aims to tackle emotional toll of type 1 diabetes
Symptom relief Recruiting nowThis research will compare a psychological intervention ("ACT1VATE") versus diabetes self-management education and support (DSME/S; usual care) in improving clinical, behavioral, psychosocial, process, and cost outcomes among adults with poorly controlled type 1 diabetes (T1D) wh…
Phase: PHASE2 • Sponsor: Scripps Whittier Diabetes Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can text reminders help black and latinx women stay HIV-Free?
Prevention Recruiting nowTaking a daily anti-HIV pill can protect people from HIV infection. This is called preexposure prophylaxis \[PrEP\]. Many cisgender women and trans individuals do not know this medication is available; others struggle to take the pill every day. It is important to understand atti…
Phase: NA • Sponsor: Columbia University • Aim: Prevention
Last updated Jun 26, 2026 13:00 UTC
-
Can a 16-Session program tame ADHD homework chaos? new study aims to find out
Symptom relief OngoingThe purpose of this current study is to conduct a conceptual replication with an independent evaluation team of the randomized controlled trial conducted by Langberg and colleagues, which demonstrated the efficacy of the Homework, Organization, and Planning Skills (HOPS) interven…
Phase: NA • Sponsor: Children's Hospital of Philadelphia • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC